DK3883936T3 - Nye heterocykliske forbindelser - Google Patents
Nye heterocykliske forbindelser Download PDFInfo
- Publication number
- DK3883936T3 DK3883936T3 DK19809026.8T DK19809026T DK3883936T3 DK 3883936 T3 DK3883936 T3 DK 3883936T3 DK 19809026 T DK19809026 T DK 19809026T DK 3883936 T3 DK3883936 T3 DK 3883936T3
- Authority
- DK
- Denmark
- Prior art keywords
- heterocyclic compounds
- new heterocyclic
- new
- compounds
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18207725 | 2018-11-22 | ||
| PCT/EP2019/081870 WO2020104494A1 (en) | 2018-11-22 | 2019-11-20 | New heterocyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3883936T3 true DK3883936T3 (da) | 2023-09-18 |
Family
ID=64453331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19809026.8T DK3883936T3 (da) | 2018-11-22 | 2019-11-20 | Nye heterocykliske forbindelser |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US20210387999A1 (da) |
| EP (1) | EP3883936B1 (da) |
| JP (1) | JP7444882B2 (da) |
| KR (1) | KR20210094540A (da) |
| CN (1) | CN113166170A (da) |
| AR (1) | AR117139A1 (da) |
| AU (1) | AU2019383500A1 (da) |
| BR (1) | BR112021009348A2 (da) |
| CA (1) | CA3119506A1 (da) |
| CL (1) | CL2021001330A1 (da) |
| CO (1) | CO2021007056A2 (da) |
| CR (1) | CR20210247A (da) |
| DK (1) | DK3883936T3 (da) |
| ES (1) | ES2955037T3 (da) |
| FI (1) | FI3883936T3 (da) |
| HR (1) | HRP20231083T1 (da) |
| HU (1) | HUE062913T2 (da) |
| IL (1) | IL283333B1 (da) |
| LT (1) | LT3883936T (da) |
| MA (1) | MA55131B1 (da) |
| MX (1) | MX2021005714A (da) |
| PE (1) | PE20211870A1 (da) |
| PH (1) | PH12021551167A1 (da) |
| PL (1) | PL3883936T3 (da) |
| PT (1) | PT3883936T (da) |
| RS (1) | RS64579B1 (da) |
| SG (1) | SG11202104206SA (da) |
| SI (1) | SI3883936T1 (da) |
| TW (1) | TWI825227B (da) |
| WO (1) | WO2020104494A1 (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR114136A1 (es) | 2017-10-10 | 2020-07-29 | Hoffmann La Roche | Compuestos heterocíclicos |
| EP3717477B1 (en) | 2017-11-28 | 2022-07-20 | F. Hoffmann-La Roche AG | New heterocyclic compounds |
| WO2019134985A1 (en) | 2018-01-08 | 2019-07-11 | F. Hoffmann-La Roche Ag | Octahydropyrido[1,2-alpha]pyrazines as magl inhibitors |
| EP3837263A1 (en) | 2018-08-13 | 2021-06-23 | F. Hoffmann-La Roche AG | New heterocyclic compounds as monoacylglycerol lipase inhibitors |
| US20210094971A1 (en) * | 2019-09-09 | 2021-04-01 | Hoffmann-La Roche Inc. | Heterocyclic compounds |
| EP4028403B1 (en) | 2019-09-12 | 2023-11-22 | F. Hoffmann-La Roche AG | 4,4a,5,7,8,8a-hexapyrido[4,3-b][1,4]oxazin-3-one compounds as magl inhibitors |
| US20240101552A1 (en) * | 2020-09-18 | 2024-03-28 | Shanghai Pharmaceuticals Holding Co., Ltd. | Carbonyl heterocyclic compound and application thereof |
| WO2023130043A1 (en) * | 2021-12-29 | 2023-07-06 | Psy Therapeutics, Inc. | Monoacylglycerol lipase inhibitors and use thereof for the treatment of anxiety |
| WO2023130050A1 (en) * | 2021-12-29 | 2023-07-06 | Psy Therapeutics, Inc. | Monoacylglycerol lipase inhibitors and use thereof for the treatment and management of pain |
| AR128333A1 (es) * | 2022-01-25 | 2024-04-17 | Hoffmann La Roche | Nuevos compuestos heterociclicos |
| WO2023247670A1 (en) * | 2022-06-24 | 2023-12-28 | F. Hoffmann-La Roche Ag | New heterocyclic-carbonyl-cyclic compounds as magl inhibitors |
| WO2024033277A1 (en) | 2022-08-08 | 2024-02-15 | F. Hoffmann-La Roche Ag | New heterocyclic compounds |
| WO2024033479A1 (en) * | 2022-08-11 | 2024-02-15 | Remynd N.V. | (aza)spiroheptane derivatives for the treatment of neurodegenerative disorders |
| WO2024061853A1 (en) * | 2022-09-20 | 2024-03-28 | F. Hoffmann-La Roche Ag | Fluorescent probes for magl |
| WO2024088922A1 (en) * | 2022-10-24 | 2024-05-02 | F. Hoffmann-La Roche Ag | Heterocyclic compounds as inhibitors of monoacylglycerol lipase (magl) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7579495B2 (en) | 2003-12-19 | 2009-08-25 | Momentive Performance Materials Inc. | Active-releasing cyclic siloxanes |
| KR101481872B1 (ko) | 2009-09-10 | 2015-01-12 | 에프. 호프만-라 로슈 아게 | Ｊａｋ의 억제제 |
| WO2011059118A1 (ko) | 2009-11-10 | 2011-05-19 | Kim Hyun Jeen | 후각인지능력 검사 시스템 |
| JP5990297B2 (ja) | 2015-03-03 | 2016-09-14 | タイヨーエレック株式会社 | 遊技機 |
| WO2016158956A1 (ja) * | 2015-03-30 | 2016-10-06 | 武田薬品工業株式会社 | 複素環化合物 |
| CN107849015B (zh) | 2015-05-21 | 2021-03-19 | 葛兰素知识产权发展有限公司 | 作为pad4抑制剂的苯并咪唑衍生物 |
| BR112018000041A2 (pt) | 2015-07-31 | 2018-09-04 | Pfizer Inc. | Derivados de carbamato de 1,1,1-trifluoro-3- hidroxipropan-2-ila e derivados de carbamato de 1,1,1-trifluoro-4-hidroxibutan-2-ila como inibidores de magl |
| US10385057B2 (en) | 2015-11-20 | 2019-08-20 | Lundbeck La Jolla Research Center, Inc. | Pyrazole compounds and methods of making and using same |
-
2019
- 2019-11-20 EP EP19809026.8A patent/EP3883936B1/en active Active
- 2019-11-20 JP JP2021528972A patent/JP7444882B2/ja active Active
- 2019-11-20 PT PT198090268T patent/PT3883936T/pt unknown
- 2019-11-20 CN CN201980077284.5A patent/CN113166170A/zh active Pending
- 2019-11-20 DK DK19809026.8T patent/DK3883936T3/da active
- 2019-11-20 SG SG11202104206SA patent/SG11202104206SA/en unknown
- 2019-11-20 WO PCT/EP2019/081870 patent/WO2020104494A1/en active Application Filing
- 2019-11-20 CR CR20210247A patent/CR20210247A/es unknown
- 2019-11-20 CA CA3119506A patent/CA3119506A1/en active Pending
- 2019-11-20 HR HRP20231083TT patent/HRP20231083T1/hr unknown
- 2019-11-20 ES ES19809026T patent/ES2955037T3/es active Active
- 2019-11-20 HU HUE19809026A patent/HUE062913T2/hu unknown
- 2019-11-20 MA MA55131A patent/MA55131B1/fr unknown
- 2019-11-20 PE PE2021000714A patent/PE20211870A1/es unknown
- 2019-11-20 RS RS20230788A patent/RS64579B1/sr unknown
- 2019-11-20 KR KR1020217015287A patent/KR20210094540A/ko unknown
- 2019-11-20 IL IL283333A patent/IL283333B1/en unknown
- 2019-11-20 SI SI201930619T patent/SI3883936T1/sl unknown
- 2019-11-20 LT LTEPPCT/EP2019/081870T patent/LT3883936T/lt unknown
- 2019-11-20 MX MX2021005714A patent/MX2021005714A/es unknown
- 2019-11-20 PL PL19809026.8T patent/PL3883936T3/pl unknown
- 2019-11-20 AU AU2019383500A patent/AU2019383500A1/en active Pending
- 2019-11-20 FI FIEP19809026.8T patent/FI3883936T3/fi active
- 2019-11-20 BR BR112021009348-6A patent/BR112021009348A2/pt unknown
- 2019-11-21 AR ARP190103417A patent/AR117139A1/es unknown
- 2019-11-21 TW TW108142267A patent/TWI825227B/zh active
-
2021
- 2021-05-20 CL CL2021001330A patent/CL2021001330A1/es unknown
- 2021-05-20 US US17/325,934 patent/US20210387999A1/en active Pending
- 2021-05-21 PH PH12021551167A patent/PH12021551167A1/en unknown
- 2021-05-28 CO CONC2021/0007056A patent/CO2021007056A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3883936T3 (da) | Nye heterocykliske forbindelser | |
| DK3436444T3 (da) | Heterocyklisk forbindelse | |
| DK3866587T3 (da) | Overvågning af husdyr | |
| DK3565806T3 (da) | Nye phenylderivater | |
| DK3442980T3 (da) | Heterocykliske forbindelser som ret-kinase-hæmmere | |
| DK3464272T3 (da) | Nye heterocykliske derivater som SHP2-inhibitorer | |
| MA45940A (fr) | Composé hétérocyclique | |
| ES2967983T3 (es) | Compuestos | |
| DK3615527T3 (da) | Nye azaquinolin-derivater | |
| DK3371190T3 (da) | Heterocykliske forbindelser som pi3k-gamma-inhibitorer | |
| DK3728252T3 (da) | 4-azaindolforbindelser | |
| DK3810587T3 (da) | Substituerede alkoxypyridinylindolsulfonamider | |
| MA47573A (fr) | Inhibiteurs de dihydrobenzofurane glycosidase substitués | |
| DK3612519T3 (da) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser | |
| DK3468975T3 (da) | Nye antibakterielle forbindelser | |
| DK3768669T3 (da) | Piperazinazaspiroderivater | |
| DK3737403T3 (da) | Modificerede adenovira | |
| DK3823970T3 (da) | Yderligere substituerede triazoloquinoxalinderivater | |
| DK3823971T3 (da) | Substituerede triazol-quinoxalin-derivater | |
| DK3762378T3 (da) | Herbicide forbindelser | |
| DK3873472T3 (da) | Nye pyridaziner | |
| DK3450436T3 (da) | Kondenseret heterocyklisk forbindelse | |
| DK3796975T3 (da) | Sulfonylaminobenzamidderivater | |
| DK3672941T3 (da) | Pyridylpyridonforbindelser | |
| MA52297A (fr) | Composé hétérocyclique |